Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Alberta

$2,222,325.00

Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants? - The HiLo-Trial

EF 2019-20

Résumé
Preterm birth, or birth before 37 weeks gestation, is increasingly common, occurring in 8% of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks gestation. At this gestational age, the lungs are not fully developed and it is not uncommon for infants to have problems breathing at the time of birth. One complication that can arise is when an infant stops breathing and needs to be resuscitated. When preterm babies need to be resuscitated doctors must take special care because of the small infant size and the immaturity of the brain and lungs. Oxygen is used to resuscitate babies who need it, but unfortunately there is disagreement about the best oxygen concentration to use. Oxygen concentration is important because both too much and too little oxygen can cause brain injury. Our research aims to fill this knowledge gap by participating in an international clinical trial to compare the effects of resuscitating babies less than 29 weeks gestational age with either a low oxygen concentration or a high oxygen concentration. The oxygen concentrations have been selected using the best available knowledge. During the first 12 months of the clinical trial we will treat all babies less than 29 weeks gestation who need resuscitation with the oxygen concentration we are randomly assigned. After 12 months we will reassess and then in the next 12 months we will treat babies using the other oxygen concentration. After the trial we will determine whether the babies resuscitated with lower oxygen or those resuscitated with higher oxygen have better survival and long-term health outcomes. Our research fills a critical knowledge gap in the care of extremely preterm babies and will impact their survival both here in Canada and internationally.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
408711
Name
Schmoelzer Georg
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Randomized Controlled Trials
Projecttitle
Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants? - The HiLo-Trial
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$2,222,325
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Clinical Trial; Delivery Room; Neonatal Resuscitation; Preterm Infants
Abstract
Preterm birth, or birth before 37 weeks gestation, is increasingly common, occurring in 8% of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks gestation. At this gestational age, the lungs are not fully developed and it is not uncommon for infants to have problems breathing at the time of birth. One complication that can arise is when an infant stops breathing and needs to be resuscitated. When preterm babies need to be resuscitated doctors must take special care because of the small infant size and the immaturity of the brain and lungs. Oxygen is used to resuscitate babies who need it, but unfortunately there is disagreement about the best oxygen concentration to use. Oxygen concentration is important because both too much and too little oxygen can cause brain injury. Our research aims to fill this knowledge gap by participating in an international clinical trial to compare the effects of resuscitating babies less than 29 weeks gestational age with either a low oxygen concentration or a high oxygen concentration. The oxygen concentrations have been selected using the best available knowledge. During the first 12 months of the clinical trial we will treat all babies less than 29 weeks gestation who need resuscitation with the oxygen concentration we are randomly assigned. After 12 months we will reassess and then in the next 12 months we will treat babies using the other oxygen concentration. After the trial we will determine whether the babies resuscitated with lower oxygen or those resuscitated with higher oxygen have better survival and long-term health outcomes. Our research fills a critical knowledge gap in the care of extremely preterm babies and will impact their survival both here in Canada and internationally.
Competitiondate
201909
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Schmoelzer, Georg; Asztalos, Elizabeth V; Shah, Prakeshkumar; Tarnow-Mordi, William; Vento, Maximo
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $2,222,325~ $0~